Sort by
Refine Your Search
-
to neuromuscular diseases and translating this knowledge into developing novel therapeutic solutions that is of direct benefit to neurological disorders. The activity of the Neurogenetics Research Group (Lead
-
Multiple Sclerosis (OCTOPUS), based in the Department of Neuroinflammation, is a multi-arm multi-stage (MAMS) adaptive platform trial that aims to speed up the development of re-purposed or novel treatments
-
translating this knowledge into developing novel therapeutic solutions that is of direct benefit to neurological disorders such as motor neurone disease, Alzheimer’s disease and neuromuscular disease. We
-
of prostate cancer imaging trials within the Centre for Medical Imaging. The CRF will lead clinical trial assessment workflows, oversee patient recruitment and safety, contribute to protocol development, and